Overview
X-linked intellectual disability-cerebellar hypoplasia syndrome (also known as OPHN1-related X-linked intellectual disability or oligophrenin-1-related cerebellar hypoplasia) is a rare genetic condition primarily affecting males, caused by mutations in the OPHN1 gene located on the X chromosome. The disorder is characterized by the combination of intellectual disability, which ranges from moderate to severe, and underdevelopment (hypoplasia) of the cerebellum — the part of the brain responsible for coordination, balance, and fine motor control. The condition affects the central nervous system predominantly, with brain MRI typically revealing cerebellar hypoplasia, particularly of the vermis, and in some cases enlargement of the cerebral ventricles (ventriculomegaly). Key clinical features include intellectual disability with delayed speech and language development, motor coordination difficulties (ataxia), strabismus (misalignment of the eyes), and seizures in some affected individuals. Behavioral abnormalities, including hyperactivity and sometimes aggressive behavior, may also be present. Affected males may show characteristic facial features such as a long face, prominent ears, and a broad nasal bridge, though these can be subtle. Carrier females are typically unaffected or may show mild cognitive difficulties. There is currently no cure or disease-specific treatment for this condition. Management is supportive and multidisciplinary, focusing on early intervention programs, speech and language therapy, physical therapy for motor difficulties, occupational therapy, and special educational support. Seizures, when present, are managed with standard antiepileptic medications. Regular neurological and developmental follow-up is recommended to optimize outcomes and quality of life.
Also known as:
Clinical phenotype terms— hover any for plain English:
X-linked recessive
Carried on the X chromosome; typically affects males more than females
Infantile
Begins in infancy, roughly 1 month to 2 years old
Treatments
No FDA-approved treatments are currently listed for X-linked intellectual disability-cerebellar hypoplasia syndrome.
View clinical trials →Clinical Trials
View all trials with filters →No actively recruiting trials found for X-linked intellectual disability-cerebellar hypoplasia syndrome at this time.
New trials open frequently. Follow this disease to get notified.
Specialists
View all specialists →No specialists are currently listed for X-linked intellectual disability-cerebellar hypoplasia syndrome.
Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Travel Grants
No travel grants are currently matched to X-linked intellectual disability-cerebellar hypoplasia syndrome.
Community
No community posts yet. Be the first to share your experience with X-linked intellectual disability-cerebellar hypoplasia syndrome.
Start the conversation →Latest news about X-linked intellectual disability-cerebellar hypoplasia syndrome
No recent news articles for X-linked intellectual disability-cerebellar hypoplasia syndrome.
Follow this condition to be notified when news becomes available.
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Common questions about X-linked intellectual disability-cerebellar hypoplasia syndrome
What is X-linked intellectual disability-cerebellar hypoplasia syndrome?
X-linked intellectual disability-cerebellar hypoplasia syndrome (also known as OPHN1-related X-linked intellectual disability or oligophrenin-1-related cerebellar hypoplasia) is a rare genetic condition primarily affecting males, caused by mutations in the OPHN1 gene located on the X chromosome. The disorder is characterized by the combination of intellectual disability, which ranges from moderate to severe, and underdevelopment (hypoplasia) of the cerebellum — the part of the brain responsible for coordination, balance, and fine motor control. The condition affects the central nervous system
How is X-linked intellectual disability-cerebellar hypoplasia syndrome inherited?
X-linked intellectual disability-cerebellar hypoplasia syndrome follows a x-linked recessive inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.
At what age does X-linked intellectual disability-cerebellar hypoplasia syndrome typically begin?
Typical onset of X-linked intellectual disability-cerebellar hypoplasia syndrome is infantile. Age of onset can vary across affected individuals.